Premium Nahrungsergänzungsmittel | artgerecht

COPD Stages: GOLD 1-4 Explained Simply

COPD stages describe the severity of chronic obstructive pulmonary disease. Classification follows GOLD criteria and guides individualized treatment decisions.

Regular tips about health Regular tips about health

Things worth knowing about "COPD stages"

COPD stages describe the severity of chronic obstructive pulmonary disease. Classification follows GOLD criteria and guides individualized treatment decisions.

What are COPD Stages?

COPD (Chronic Obstructive Pulmonary Disease) is a progressive respiratory condition characterized by persistent airflow limitation. To assess disease severity and guide treatment, COPD is classified into distinct stages according to the criteria of the GOLD Initiative (Global Initiative for Chronic Obstructive Lung Disease).

The GOLD Stages of COPD

The GOLD classification is primarily based on spirometry results, specifically the FEV1 value (Forced Expiratory Volume in one second) – the amount of air a person can forcefully exhale in one second. FEV1 is expressed as a percentage of the predicted normal value.

GOLD 1 (Mild): FEV1 ≥ 80% of predicted. Airflow limitation is mild. Many patients experience few or no symptoms at this stage.
GOLD 2 (Moderate): FEV1 50–79% of predicted. Shortness of breath on exertion and chronic cough become more noticeable. Many patients are first diagnosed at this stage.
GOLD 3 (Severe): FEV1 30–49% of predicted. Quality of life is significantly impaired. Breathlessness occurs with minimal exertion, and exacerbations (sudden worsening episodes) become more frequent.
GOLD 4 (Very Severe): FEV1 < 30% of predicted. Severe airflow limitation is present even at rest. Chronic respiratory failure may develop, and the prognosis is serious.

The ABCD Assessment Tool

In addition to spirometric grading, the GOLD Initiative introduced the ABCD assessment tool to incorporate symptoms and exacerbation risk into treatment planning. Two validated questionnaires are used:

mMRC Scale (Modified Medical Research Council): evaluates the severity of breathlessness.
CAT Score (COPD Assessment Test): measures the overall impact of COPD on daily life and quality of life.

Combining the lung function grade (GOLD 1–4) with the ABCD category enables individualized therapy recommendations tailored to each patient.

Causes and Risk Factors

The leading cause of COPD is cigarette smoking. Additional risk factors include:

Long-term exposure to dust, chemical fumes, or air pollution
Genetic factors (e.g., alpha-1-antitrypsin deficiency)
Recurrent respiratory infections during childhood

Symptoms by Stage

Symptoms vary depending on disease severity and may include:

Chronic cough, often with mucus production (all stages)
Breathlessness on exertion (from stage 2 onward)
Breathlessness at rest and bluish discoloration of the lips or fingertips (advanced stages)
Unintentional weight loss and muscle weakness (severe COPD)
Frequent respiratory infections

Diagnosis

Diagnosing COPD and determining its stage involves:

Spirometry: Measurement of FEV1 and FVC (Forced Vital Capacity) to assess airflow limitation
Medical history and physical examination
Blood gas analysis: To evaluate oxygen and carbon dioxide levels in the blood
Imaging: Chest X-ray or CT scan to rule out other conditions

Treatment by Stage

COPD treatment is tailored to the individual stage and risk profile of each patient:

GOLD 1 (Mild)

Smoking cessation is the single most effective intervention
Short-acting bronchodilators as needed (e.g., salbutamol)
Vaccinations (influenza, pneumococcal)

GOLD 2 (Moderate)

Regular use of long-acting bronchodilators (LABA or LAMA)
Pulmonary rehabilitation

GOLD 3 (Severe)

Combination therapy with LABA and LAMA
Inhaled corticosteroids (ICS) in combination for patients with frequent exacerbations
Supplemental oxygen therapy if needed

GOLD 4 (Very Severe)

Long-term oxygen therapy (> 15 hours per day for chronic hypoxemia)
Non-invasive ventilation (NIV)
Lung volume reduction surgery or lung transplantation in selected cases
Palliative care support

Prognosis and Disease Course

COPD is a chronic, progressive disease with no cure. However, with consistent treatment and lifestyle changes – most importantly quitting smoking – the progression of the disease can be significantly slowed. Early diagnosis and stage-appropriate therapy substantially improve quality of life and long-term outcomes.

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024 Report. Available at: www.goldcopd.org
Vogelmeier CF et al. – Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. American Journal of Respiratory and Critical Care Medicine. 2017;195(5):557–582.
National Institute for Health and Care Excellence (NICE): Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline NG115. 2019. Available at: www.nice.org.uk

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category